The personalized approach to choosing a contraceptive: weighing the pros and cons

The personalized approach to choosing a contraceptive: weighing the pros and cons

The article presents the latest data on the risks of complications development on the background of the use of combined oral contraceptives, as well as the treatment effects of the use of hormonal contraceptives.

Bibliographic Details
Main Authors:	Yu E Dobrokhotova, E I Borovkova
Format:	Article
Language:	Russian
Published:	IP Berlin A.V. 2017-06-01
Series:	Гинекология
Subjects:	combined oral contraception thrombosis thromboembolism estradiol avalerate dienogest combined oral contraceptives
Online Access:	https://gynecology.orscience.ru/2079-5831/article/viewFile/28619/pdf

Similar Items

Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study
by: Briggs P, et al.
Published: (2016-09-01)

Prolonged schemes of combined hormonal contraceptives assignment
by: V V Korennaya, et al.
Published: (2015-06-01)

Real clinical practice and contraception for young women with children
by: Natalia V. Aganezova, et al.
Published: (2021-03-01)

Combined oral contraceptives with shortened hormone-free interval. Proven advantages of the therapy regime
by: G. B. Dikke
Published: (2019-10-01)

Estradiol valerate and dienogest in hormonal contraception. Acceptability and effectiveness in real clinical practice
by: E. R. Dovletkhanova, et al.
Published: (2018-09-01)

MENORRHAGIA: ARE THERE ANY SOLUTIONS?
by: Y. E. Dobrokhotova, et al.
Published: (2016-12-01)

FIXED PROLONGED REGIME OF COMBINED ORAL CONTRACEPTIVES (COC) INTAKE IN SOLUTION OF CLASSIC CONTRACEPTION ISSUES (LITERATURE REVIEW)
by: V. N. Prilepskaya, et al.
Published: (2017-07-01)

Dysmenorrhea, endometriosis, adenomyosis: clinical and pathogenetic relationships
by: A.L.Unanian, et al.
Published: (2018-01-01)

Dysmenorrhea, endometriosis, adenomyosis: clinical and pathogenetic relationships
by: A L Unanian, et al.
Published: (2018-02-01)

Venous thromboembolism associated with combined oral contraceptive use: a single-institution experience
by: Yong-Su Jang, et al.
Published: (2021-07-01)

Comparison of risks of thromboembolism of drospirenone-containing and nondrospirenone -containing combined oral contraceptive use: A meta-analysis
by: Wan-Lin Zhang, et al.
Published: (2021-01-01)

Effect of combined oral contraceptives with estrogen identical to natural estrogen on the metabolic profile and body composition in females during the menopausal transition
by: Veronika I. Komedina, et al.
Published: (2023-01-01)

Contraception with estradiol valerate and dienogest: adherence to the method
by: Fruzzetti F, et al.
Published: (2019-05-01)

Obesity and contraceptive use: impact on cardiovascular risk
by: Giuseppe M.C. Rosano, et al.
Published: (2022-12-01)

Noncontraceptive effects of combined oral contraceptives: benefits and risks of use
by: A L Unanyan, et al.
Published: (2017-04-01)

Comparison of Combined Parenteral and Oral Hormonal Contraceptives: A Systematic Review and Meta-Analysis of Randomized Trials
by: Gábor Vleskó, et al.
Published: (2024-01-01)

Progesterone contraceptives: a place in practical gynecology (to practitioner aid)
by: Y E Dobrokhotova, et al.
Published: (2018-06-01)

HORMONAL CONTRACEPTION AND MAGNESIUM DEFICIENCY: A SUBANALYSIS OF THE MAGYN STUDY
by: D. V. Blinov, et al.
Published: (2017-06-01)

ADMINISTRATION OF A COMBINED ORAL CONTRACEPTIVE CONTAINING ESTRADIOL VALERATE/DIENOGEST (E2V/DNG) BY WOMEN WITH MENORRHAGIA
by: E. R. Dovlethanova, et al.
Published: (2017-12-01)

Emergency contraception: ¿how, when and with what?
by: Álvaro Monterrosa Castro
Published: (2006-04-01)

HORMONAL CONTRACEPTION AS TREATMENT FOR ANOMALOUS UTERINE BLEEDING
by: I. V. Kuznetsova
Published: (2018-01-01)

A Multi-Institutional Informed Consent Proposal as a Prevention Tool for Combined Oral Contraceptive Intake and Thrombotic Risk
by: Marina Vinciguerra, et al.
Published: (2023-03-01)

Administration of combined contraceptive containing dienogest and ethinyl estradiol for endometriosis
by: L. V. Yerofeyeva
Published: (2016-12-01)

Risks of venous thromboembolic complications in related to combined oral contraceptives
by: K. A. Gabelova, et al.
Published: (2022-01-01)

Investigating cardiovascular risk in premenopausal women on oral contraceptives: Systematic review with meta-analysis
by: Oyesanmi A. Fabunmi, et al.
Published: (2023-04-01)

Complex questions about combined hormonal contraception: A review
by: Vera N. Prilepskaya, et al.
Published: (2023-07-01)

Reproductive behavior of medical students: realities of contraceptive choice
by: T A Oboskalova, et al.
Published: (2018-06-01)

Influence of genetic polymorphisms on fibrinogen level at taking of combined oral contraceptives
by: D. R. Gamyrkina, et al.
Published: (2016-03-01)

Prolonged regimens for combined oral contraceptives
by: I V Kuznetsova
Published: (2017-02-01)

Dysmenorrhea: effectiveness and acceptability of treatment with a drug containing 2 mg of chloromadinone acetate and 0.03 mg of ethinyl estradiol
by: V N Prilepskaia, et al.
Published: (2017-06-01)

Topical issues in combined oral contraceptives usage
by: S O Dubrovina
Published: (2018-04-01)

Combined oral contraceptives with natural estrogen and sexual function: the optimal method of contraception for women of different ages
by: Svetlana V Yureneva, et al.
Published: (2019-02-01)

Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives?
by: Fruzzetti F, et al.
Published: (2018-11-01)

The effect of lavender on mood disorders associated with the use of combined oral contraceptives (COCs): a triple-blinded randomized controlled trial
by: Mina Naghdi, et al.
Published: (2024-03-01)

PREMENSTRUAL SYNDROME: FROM THEORY TO PRACTICE
by: O. V. Yakushevskaya
Published: (2016-12-01)

Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk
by: Laure Morimont, et al.
Published: (2021-12-01)

The use of combined hormonal contraception in the context of the COVID-19 pandemic
by: A. T. Uruymagova, et al.
Published: (2021-10-01)

Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review
by: Tekle E, et al.
Published: (2022-09-01)

Effects of oral contraceptives on spatial cognition depend on pharmacological properties and phase of the contraceptive cycle
by: Elizabeth Hampson, et al.
Published: (2022-09-01)

Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort
by: Gbènankpon Mathias Houvèssou, et al.
Published: (2024-02-01)